Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Dermatology

Derm Infectious Disease

Clinical, laboratory, and interferon-alpha response characteristics of patients with chilblain-like lesions during the COVID-19 pandemic

JAMA | Feb 24, 2021 Derm Infectious Disease

Pooled results of two randomized phase III trials evaluating VP-102, a drug- device combination product containing cantharidin 0.7% (w/v) for the treatment of molluscum contagiosum

American Journal of Clinical Dermatology | Feb 23, 2021 Derm Infectious Disease

Diagnostic accuracy of aspergillus‐specific antibodies for chronic pulmonary aspergillosis: A systematic review and meta‐analysis

Mycoses | Feb 21, 2021 Derm Infectious Disease

Correlates of injection‐related wounds and skin infections amongst persons who inject drugs and use a syringe service program: A single center study

International Wound Journal | Feb 20, 2021 Derm Infectious Disease

Risk factors for candidaemia: A prospective multi‐centre case‐control study

Mycoses | Feb 16, 2021 Derm Infectious Disease

Effective treatment of cutaneous mold infections by antimicrobial blue light that is potentiated by quinine

The Journal of Infectious Diseases | Feb 06, 2021 Derm Infectious Disease

Clinical experience with isavuconazole in healthy volunteers and patients with invasive aspergillosis in China, and the results from an exposure–response analysis

Mycoses | Feb 04, 2021 Derm Infectious Disease

The clinical spectrum of COVID-19-associated cutaneous manifestations: An Italian multicentre study of 200 adult patients

Journal of the American Academy of Dermatology | Jan 21, 2021 Derm Infectious Disease

Safety and efficacy of oral and/or intravenous tedizolid phosphate from a randomized phase 3 trial in adolescents with acute bacterial skin and skin structure infections

The Pediatric Infectious Disease Journal | Jan 13, 2021 Derm Infectious Disease

Safety and efficacy of oral and/or intravenous tedizolid phosphate from a randomized phase 3 trial in adolescents with acute bacterial skin and skin structure infections

The Pediatric Infectious Disease Journal | Jan 07, 2021 Derm Infectious Disease

« Prev 1 … 4 5 6 7 8 … 28 Next »

Clinical, laboratory, and interferon-alpha response characteristics of patients with chilblain-like lesions during the COVID-19 pandemic

Pooled results of two randomized phase III trials evaluating VP-102, a drug- device combination product containing cantharidin 0.7% (w/v) for the treatment of molluscum contagiosum

Diagnostic accuracy of aspergillus‐specific antibodies for chronic pulmonary aspergillosis: A systematic review and meta‐analysis

Correlates of injection‐related wounds and skin infections amongst persons who inject drugs and use a syringe service program: A single center study

Risk factors for candidaemia: A prospective multi‐centre case‐control study

Effective treatment of cutaneous mold infections by antimicrobial blue light that is potentiated by quinine

Clinical experience with isavuconazole in healthy volunteers and patients with invasive aspergillosis in China, and the results from an exposure–response analysis

The clinical spectrum of COVID-19-associated cutaneous manifestations: An Italian multicentre study of 200 adult patients

Safety and efficacy of oral and/or intravenous tedizolid phosphate from a randomized phase 3 trial in adolescents with acute bacterial skin and skin structure infections

Safety and efficacy of oral and/or intravenous tedizolid phosphate from a randomized phase 3 trial in adolescents with acute bacterial skin and skin structure infections

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Top Foods to Combat Winter Illness

Pulmonary Embolism: MCQs Challenge

The Role of Nutrition in Enhancing Fertility for Men and Women

Clinical, laboratory, and interferon-alpha response characteristics of patients with chilblain-like lesions during the COVID-19 pandemic

Pooled results of two randomized phase III trials evaluating VP-102, a drug- device combination product containing cantharidin 0.7% (w/v) for the treatment of molluscum contagiosum

Diagnostic accuracy of aspergillus‐specific antibodies for chronic pulmonary aspergillosis: A systematic review and meta‐analysis

Correlates of injection‐related wounds and skin infections amongst persons who inject drugs and use a syringe service program: A single center study

Risk factors for candidaemia: A prospective multi‐centre case‐control study

Effective treatment of cutaneous mold infections by antimicrobial blue light that is potentiated by quinine

Clinical experience with isavuconazole in healthy volunteers and patients with invasive aspergillosis in China, and the results from an exposure–response analysis

The clinical spectrum of COVID-19-associated cutaneous manifestations: An Italian multicentre study of 200 adult patients

Safety and efficacy of oral and/or intravenous tedizolid phosphate from a randomized phase 3 trial in adolescents with acute bacterial skin and skin structure infections

Safety and efficacy of oral and/or intravenous tedizolid phosphate from a randomized phase 3 trial in adolescents with acute bacterial skin and skin structure infections

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Top Foods to Combat Winter Illness

Pulmonary Embolism: MCQs Challenge

The Role of Nutrition in Enhancing Fertility for Men and Women

Select Specialty

Select Topic